Riskpilot← Back to searchSign inGet full accessVesper Bio ApS
APSActiveCVR 32879861Hauser Plads 10, 4.Research and experimental development on natural sciences and engineering · NACE 7210Est. 20108 employeeswww.vesperbio.com
Revenue 2025
DKK -36,4M
-46% vs 2024
EBITDA margin
116.6%
+42% vs 2024
Equity ratio
-344.9%
Financial strength
Net profit 2025
DKK -48,2M
+28% vs 2024
| Revenue | DKK -36,4M | -46% |
| EBITDA | DKK -42,5M | +42% |
| Net profit | DKK -48,2M | +28% |
| Total assets | DKK 65,9M | -6% |
| Equity | DKK -227,4M | -27% |
| Employees | 8 | — |
Legal name
Vesper Bio ApS
CVR number
32879861
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19. april 2010
Share capital
DKK 355.952
Employees
8 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør alene.
Company purpose
Selskabets formål er at drive forsknings- og udviklingsvirksomhed rettet mod udvikling af lægemidler til behandling af hjernesygdomme, diabetes, diabetes-relaterede metaboliske, sygdomme, fedme og/eller fedmerelaterede sygdomme, samt at udføre aktiviteter, der er forbundet hermed.
Address
Hauser Plads 10, 4.
Phone
+4523628367
Email
jfh@vesperbio.com
Website
www.vesperbio.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -22 | — | — | — | — | — | — | — | -6.780 | -13.499 | -31.620 | -67.586 | -67.244 | -36.446 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -22 | -2.546 | -6.940 | -6.052 | -3.969 | -2.662 | -3.941 | -2.743 | -7.525 | -14.946 | -32.959 | -71.994 | -72.836 | -42.491 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -22 | -2.546 | -6.940 | -6.052 | -3.969 | -2.662 | -3.941 | -2.743 | -7.525 | -14.946 | -32.959 | -71.994 | -72.836 | -42.491 |
| Net financials | 0 | -0 | -0 | -13 | -34 | -18 | -52 | -26 | -430 | -1.525 | -3.901 | -8.778 | -14.018 | -20.295 |
| Profit before tax | -22 | -2.546 | -6.940 | -6.065 | -4.003 | -2.680 | -3.992 | -2.769 | -7.955 | -16.471 | -36.860 | -80.772 | -86.853 | -62.786 |
| Tax | -5 | 8 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -28.209 | -20.347 | -14.585 |
| Net profit | -16 | -2.554 | -6.940 | -6.065 | -4.003 | -2.680 | -3.992 | -2.769 | -7.955 | -16.471 | -36.860 | -52.563 | -66.506 | -48.201 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 380 | 12.939 | 6.263 | 7.973 | 4.010 | 8.981 | 5.114 | 1.776 | 5.884 | 5.275 | 25.532 | 32.181 | 69.849 | 65.946 |
| Equity | 377 | 12.575 | 5.634 | 7.069 | 3.066 | 7.886 | 3.893 | 1.124 | -6.831 | -23.303 | -60.163 | -112.726 | -179.232 | -227.433 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.464 |
| Short-term debt | 3 | 364 | 628 | 903 | 944 | 1.095 | 1.221 | 652 | 12.715 | 28.578 | 85.695 | 144.907 | 249.081 | 276.915 |
| Total debt | 3 | 364 | 628 | 903 | 944 | 1.095 | 1.221 | 652 | 12.715 | 28.578 | 85.695 | 144.907 | 249.081 | 293.379 |
EBITDA margin
-4249058400.0%
This company
15.8%
Market median
-26892774784% vs market
20122025
Equity ratio
-344.9%
This company
38.2%
Market median
-1003% vs market
20122025
Return on equity
-4820099100.0%
This company
18.4%
Market median
-26196190861% vs market
20122025
Net profit margin
-4820099100.0%
This company
8.1%
Market median
-59507396396% vs market
20122025
Asset turnover
-0.55×
This company
1.12×
Market median
-149% vs market
20122025
Debt / equity
1.29×
This company
0.62×
Market median
-108% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AN Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
PB Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
CE Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
JF Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
LUNDBECKFONDEN | Company | 66.7% | 66.7% | 2015 |
75PMK Holding ApS | Company | 20.0% | 20.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
75PMK Holding ApS
Vesper Bio ApS Board members of Vesper Bio ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Nykjær | Chief Executive Officer | 0 companies |
| Paul Brian Little | Chief Executive Officer | 0 companies |
| Christian Ellebæk Elling | Chief Executive Officer | 0 companies |
| Jacob Falck Hansen | Chief Executive Officer | 0 companies |